Paid Clinical Trials and Focus Groups by Category |
|
|
|
-
860 Peachwood Drive
United States, Florida 32720
United States
Avail Clinical Research is currently screening for clinical research study for tobacco users who don't intend to quit. Up to $400 to qualified participants.
Condition: Type 2 Diabetes
Intervention: Drug: Intensive insulin
Sponsor: Ohio University
Not yet recruiting - verified March 2010
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: NN5401; Drug: insulin detemir; Drug: insulin aspart; Drug: insulin aspart
Sponsor: Novo Nordisk
Recruiting - verified March 2010
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Linagliptin; Drug: Placebo; Drug: Glimepiride
Sponsor: Boehringer Ingelheim Pharmaceuticals
Recruiting - verified March 2010
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: NOX-E36; Drug: NOX-E36
Sponsors: Noxxon Pharma AG; Profil Institut für Stoffwechselforschung GmbH
Not yet recruiting - verified March 2010
Conditions: Type 2 Diabetes; Morbid Obesity
Intervention:
Sponsor: University Hospital, Gasthuisberg
Recruiting - verified March 2010
Conditions: Metabolic Syndrome; Diabetes; Prediabetes; Hypertension
Intervention:
Sponsor: West Virginia School of Osteopathic Medicine
Not yet recruiting - verified March 2010
Conditions: Metabolic Syndrome; Obesity; Diabetes; Cardiovascular Disease
Interventions: Behavioral: Crononutrition; Behavioral: American Heart Association
Sponsors: Instituto Cientifico y Tecnologico de Navarra, Universidad de Navarra; Hospital of Navarra
Recruiting - verified March 2010
Conditions: Healthy; Diabetes Mellitus, Type 2
Interventions: Drug: NN9925 (oral); Drug: NN9925 (i.v.); Drug: placebo; Drug: NN9925 (oral); Drug: placebo
Sponsor: Novo Nordisk
Not yet recruiting - verified March 2010
Conditions: Type 2 Diabetes; Hypogonadism
Intervention: Drug: Testosterone
Sponsor: Tameside Hospital NHS Foundation Trust
Not yet recruiting - verified November 2008
Condition: Type 1 Diabetes Mellitus
Interventions: Behavioral: Diabetes related psychological counseling and education; Device: Continuous Glucose Monitor
Sponsors: University Hospital Case Medical Center; National Institute of Mental Health (NIMH)
Not yet recruiting - verified March 2010
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: linagliptin; Drug: placebo
Sponsor: Boehringer Ingelheim Pharmaceuticals
Recruiting - verified March 2010
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: AZD1656; Drug: Gemfibrozil; Drug: Placebo
Sponsor: AstraZeneca
Not yet recruiting - verified March 2010
Conditions: Obesity; Bariatric Surgery; Morbid Obesity; Diabetes Mellitus Type 2; Diet Therapy
Interventions: Procedure: Roux-en-Y Gastric Bypass; Behavioral: Caloric Restriction
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified February 2010
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: AZD1656; Drug: Pioglitazone
Sponsor: AstraZeneca
Recruiting - verified March 2010
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Canagliflozin 100 mg; Drug: Placebo/sitagliptin 2x50 mg; Drug: Canagliflozin 300 mg
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Recruiting - verified March 2010
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: INSULIN GLARGINE; Drug: INSULIN GLULISINE
Sponsor: Sanofi-Aventis
Recruiting - verified March 2010
Conditions: Pregnancy; Weight Gain
Interventions: Behavioral: Lifestyle Intervention group; Behavioral: Standard of Care
Sponsor: Emory University
Not yet recruiting - verified March 2010
Condition: Diabetes
Intervention:
Sponsor: Beth Israel Deaconess Medical Center
Recruiting - verified March 2010
Condition: Diabetic Vascular Complications
Intervention:
Sponsor: Winthrop University Hospital
Recruiting - verified March 2010
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: NN1250; Drug: insulin glargine; Drug: NN1250; Drug: insulin aspart
Sponsor: Novo Nordisk
Recruiting - verified March 2010
Conditions: Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Polyneuropathy
Interventions: Drug: SB-509; Other: Saline
Sponsors: Sangamo Biosciences; Juvenile Diabetes Research Foundation
Recruiting - verified March 2010
Conditions: Diabetes; Obesity
Intervention: Behavioral: Lifestyle Intervention Classes
Sponsors: Emory University; American Diabetes Association; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Not yet recruiting - verified January 2010
Condition: Hypertension
Intervention: Other: Computerized reminders on hypertension intensification
Sponsors: Brigham and Women's Hospital; Robert Wood Johnson Foundation
Not yet recruiting - verified March 2010
Conditions: Diabetes; Limb Ischemia
Interventions: Other: Autologous mesenchymal stem cells from adipose tissue.; Other: Autologous mesenchymal stem cells from adipose tissue.; Other: Autologous mesenchymal stem cells from adipose tissue.
Sponsors: Fundacion Progreso y Salud, Spain; Carlos III Health Institute
Recruiting - verified January 2010
Condition: Non-Alcoholic Fatty Liver Disease
Interventions: Drug: Galvus (vitagliptin); Drug: Galvus + vitamin D
Sponsor: Ziv Hospital
Not yet recruiting - verified March 2010
Condition: Diabetic Peripheral Neuropathy
Interventions: Other: Skin biopsy; Other: Skin biopsy
Sponsors: Albany Medical College; Endo Pharmaceuticals
Recruiting - verified March 2010
Condition: Diabetic Peripheral Neuropathy
Interventions: Biological: Tanezumab; Biological: placebo
Sponsor: Pfizer
Not yet recruiting - verified March 2010
Condition: Polycystic Ovary Syndrome
Intervention: Behavioral: Nutrition Education, Dietary Counseling, and Cooking
Sponsors: Children's Hospital Boston; Thrasher Research Fund
Not yet recruiting - verified March 2010
Conditions: Diabetes Mellitus 1 or 2; Midfoot Charcot Neuroarthropathy
Interventions: Procedure: Surgery with Midfoot Fusion Bolt; Procedure: Cast treatment
Sponsor: AO Clinical Investigation and Documentation
Not yet recruiting - verified March 2010
Condition: Diabetes Mellitus, Type 2
Intervention: Drug: repaglinide
Sponsor: Novo Nordisk
Not yet recruiting - verified February 2010
Condition: Diabetes Type 2
Interventions: Drug: Insulin-Levemir; Drug: Exenatide-Bayetta; Drug: Insulin-Levemir and Exenatide-Bayetta; Device: SenseWear Pro3® armband; Device: DexCom CGM
Sponsors: Novo Nordisk; BodyMedia
Recruiting - verified June 2009
Condition: Type II Diabetes Mellitus
Intervention: Other: Spice polyphenols
Sponsor: University of California, Los Angeles
Recruiting - verified February 2010
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: NN1250; Drug: insulin glargine
Sponsor: Novo Nordisk
Recruiting - verified March 2010
Condition: Corneal Dystrophy
Intervention:
Sponsor: Frederiksberg University Hospital
Recruiting - verified January 2010
Condition: Diabetic Macular Edema
Interventions: Drug: Ranibizumab; Drug: ranibizumab
Sponsors: Johns Hopkins University; Juvenile Diabetes Research Foundation
Recruiting - verified February 2010
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Insulin glulisine; Drug: Insulin glargine; Drug: Premixed insulin (Insulin Aspart 30/70 )
Sponsor: Sanofi-Aventis
Recruiting - verified March 2010
Conditions: Schizophrenia; Schizoaffective Disorders; Schizophreniform Disorders
Interventions: Drug: Pravastatin; Drug: Placebo
Sponsors: Massachusetts General Hospital; Stanley Medical Research Institute
Not yet recruiting - verified March 2010
Condition: Type 2 Diabetes
Intervention:
Sponsors: China Cardiometabolic Registries; Roche Pharma AG; VitalStrategic Research Institute; Chinese College of Cardiovascular Physicians; China Endocrinologist Association
Not yet recruiting - verified February 2010
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: NN1250; Drug: NN1250
Sponsor: Novo Nordisk
Recruiting - verified February 2010
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: sitagliptin phosphate; Drug: Comparator: placebo to pioglitazone; Drug: Comparator: placebo to sitagliptin; Drug: Comparator: pioglitazone; Drug: Comparator: glimepiride or gliclazide; Drug: Comparator: metformin; Drug: Comparator: pioglitazone rescue therapy
Sponsor: Merck
Not yet recruiting - verified February 2010
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: sitagliptin phosphate (+) metformin hydrochloride; Drug: Comparator: metformin; Drug: Comparator: sitagliptin; Drug: Comparator: Placebo
Sponsor: Merck
Not yet recruiting - verified February 2010
Condition: Type 1 Diabetes
Interventions: Other: Closed-loop insulin delivery; Other: Standard insulin pump treatment
Sponsors: University of Cambridge; Cambridge University Hospitals NHS Foundation Trust
Not yet recruiting - verified February 2010
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Insulin Glargine; Drug: LY2189265
Sponsor: Eli Lilly and Company
Recruiting - verified March 2010
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: NN1250; Drug: insulin detemir (Levemir®); Drug: insulin aspart
Sponsor: Novo Nordisk
Recruiting - verified March 2010
Conditions: Morbid Obesity; Overweight; Normal Weight
Intervention: Procedure: Surgery
Sponsors: Fundacion IMIM; Parc de Salut Mar
Recruiting - verified October 2009
Condition: Diabetes Mellitus
Interventions: Device: Finesse; Device: Pen/Syringe (Usual injection device)
Sponsors: Calibra Medical, Inc.; Nancy Bohannon, MD, Med. Corp.; Henry Ford Health System; Northwestern University; University of Texas Southwestern Medical Center; Joslin Diabetes Center; International Diabetes Center at Park Nicollet
Recruiting - verified March 2010
Conditions: Obesity; Injury
Interventions: Behavioral: Healthy Eating/Physical Activity; Behavioral: Safety/Injury Prevention
Sponsors: HealthPartners Research Foundation; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University of Washington; University of Minnesota School of Public Health
Not yet recruiting - verified March 2010
Condition: Diabetes
Intervention:
Sponsor: Portland VA Medical Center
Recruiting - verified September 2009
Condition: Hypertension
Intervention:
Sponsors: Abbott; McKesson Canada
Recruiting - verified February 2010
Condition: Healthy Volunteers
Interventions: Dietary Supplement: Single High Dose Cholecalciferol; Dietary Supplement: Daily Dose Cholecalciferol
Sponsor: Mayo Clinic
Recruiting - verified March 2010
Condition: Type 2 Diabetes
Interventions: Behavioral: Lifestyle counseling; Behavioral: Standard care
Sponsor: The Catholic University of Korea
Recruiting - verified December 2007
Condition: Diabetes in Cystic Fibrosis Patients
Intervention: Other: Prospective cohort with an annual follow-up
Sponsor: Hospices Civils de Lyon
Recruiting - verified October 2009
Condition: Type 2 Diabetes
Interventions: Other: SMBG to guide clinical decisions; Other: SMBG and CGM
Sponsors: Park Nicollet Institute; International Diabetes Center at Park Nicollet; Abbott Diabetes Care
Recruiting - verified February 2010
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: ASP1941; Drug: Metformin; Drug: Placebo
Sponsor: Astellas Pharma Inc
Recruiting - verified March 2010
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: MP-513; Drug: MP-513; Drug: Placebo of MP-513
Sponsor: Mitsubishi Tanabe Pharma Corporation
Recruiting - verified February 2010
Condition: Cardiovascular Risk
Interventions: Other: SMART PHR; Other: usual care
Sponsors: University of Pittsburgh; Agency for Healthcare Research and Quality (AHRQ)
Not yet recruiting - verified March 2010
Condition: Acute Gout
Interventions: Drug: ACZ885; Drug: Triamcinolone acetonide
Sponsor: Novartis Pharmaceuticals
Recruiting - verified March 2010
Condition: Hypertension
Interventions: Drug: Non-ARB (standard therapy); Drug: ARB (Telmisartan)
Sponsor: Kumamoto University
Recruiting - verified June 2009
Conditions: Type 2 Diabetes Mellitus; Obesity
Interventions: Procedure: Laparoscopic Adjustable Gastric Band; Procedure: Roux-en-Y Gastric Bypass (Surgery); Other: Intensive Medical Diabetes & Weight Management; Device: Allergan Adjustable Gastric Band
Sponsors: Joslin Diabetes Center; Brigham and Women's Hospital
Recruiting - verified February 2010
Condition: Diabetes Mellitus, Type II
Intervention:
Sponsor: Postgraduate Institute of Medical Education and Research
Recruiting - verified January 2010
Condition: Type 1 Diabetes
Intervention: Biological: Mesenchymal stem cells
Sponsor: Uppsala University Hospital
Not yet recruiting - verified February 2010
Condition: Glucose Lowering
Intervention: Drug: AZD1656
Sponsor: AstraZeneca
Not yet recruiting - verified February 2010
Condition: Moderate to Severe Plaque Psoriasis
Intervention: Biological: adalimumab (Humira)
Sponsor: Abbott
Recruiting - verified February 2010
Condition: Diabetes Mellitus
Interventions: Drug: BGP-15 100 mg QD; Drug: BGP-15 100 mg BID; Drug: Placebo BID; Drug: BGP-15 200 mg QD; Drug: BGP-15 200 mg BID; Drug: BGP-15 400 mg QD
Sponsors: N-Gene Research Laboratories, Inc.; Integrium; Msource Medical Development GmbH; Kinexum LLC; Fisher Clinical Services UK Ltd; Haupt Pharma Wülfing GmbH; BARC nv
Not yet recruiting - verified February 2010
Condition: Obesity
Interventions: Behavioral: Busy Bodies/Better Bites; Behavioral: Healthy Spots/Safe Tots
Sponsors: HealthPartners Research Foundation; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Not yet recruiting - verified March 2010
Conditions: Heart Failure; Type 2 Diabetes
Intervention: Drug: insulin
Sponsors: University of Aarhus; Danish Heart Foundation; Region midtjyllands sundhedsvidenskabelige forskningsfond
Recruiting - verified February 2010
Conditions: Diabetes Mellitus Type 2; Impaired Glucose Tolerance
Interventions: Drug: canakinumab + background diabetes therapy; Drug: placebo + background diabetes therapy
Sponsor: Novartis
Recruiting - verified February 2010
Condition: Diabetes Mellitus
Interventions: Behavioral: Patient diabetes education and communication classes; Behavioral: Provider cultural competency and communication training; Behavioral: System redesign
Sponsors: University of Chicago; Merck
Not yet recruiting - verified March 2010
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: NN1250; Drug: insulin glargine
Sponsor: Novo Nordisk
Recruiting - verified March 2010
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: NN1250; Drug: insulin glargine
Sponsor: Novo Nordisk
Recruiting - verified March 2010
Condition: Healthy Volunteers
Interventions: Drug: Dapagliflozin; Drug: Dapagliflozin
Sponsors: AstraZeneca; Bristol-Myers Squibb
Recruiting - verified February 2010
Condition: Type 1 Diabetes
Interventions: Procedure: Isolated Pancreas Transplant; Drug: Intensive Insulin Therapy
Sponsor: Nantes University Hospital
Recruiting - verified March 2010
Condition: Type 1 Diabetes Mellitus
Intervention: Other: DAFNE course (Timing of delivery of education)
Sponsors: Sheffield Teaching Hospitals NHS Foundation Trust; University Hospitals, Leicester; Cambridge University Hospitals NHS Foundation Trust; University College London Hospitals; Northumbria Healthcare NHS Foundation Trust; NHS Greater Glasgow and Clyde; Norfolk and Norwich University Hospitals NHS Foundation Trust; East Lancashire Hospitals NHS Trust
Not yet recruiting - verified February 2010
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Saxagliptin; Drug: Metformin
Sponsors: Bristol-Myers Squibb; AstraZeneca
Not yet recruiting - verified February 2010
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Metformin (Diabex); Drug: Metformin (Glucophage™); Drug: Metformin (Diabex); Drug: Metformin (Glucophage™)
Sponsors: Bristol-Myers Squibb; AstraZeneca
Not yet recruiting - verified February 2010
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Dapagliflozin; Drug: Rifampin
Sponsor: Bristol-Myers Squibb
Not yet recruiting - verified February 2010
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Saxagliptin; Drug: Saxagliptin; Drug: Metformin; Drug: Metformin
Sponsors: Bristol-Myers Squibb; AstraZeneca
Not yet recruiting - verified February 2010
Condition: Diabetes Mellitus
Intervention: Drug: VIAject U-100 Insulin
Sponsors: Stanford University; Biodel; Barbara Davis Center for Childhood Diabetes
Not yet recruiting - verified February 2010
Condition: Diabetes
Intervention: Device: Subcutaneous glucose monitoring device
Sponsors: BioTex, Inc.; Eric Orzeck's Practice
Recruiting - verified February 2010
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Exenatide; Drug: LY2189265; Drug: Placebo
Sponsor: Eli Lilly and Company
Recruiting - verified March 2010
Conditions: The Null Hypothesis is That Food Rheology Will Have no Effect on These Indices.; The Alternate Hypothesis is That Increased Mechanical Stimulation Will Result in Stronger Satiation/Satiety and Reduced Energy Intake.; Further, it is Hypothesized That the Effects of Mastication Will be Less Evident in Obese Compared to Lean Individuals.
Interventions: Other: soft gum; Other: firm gum; Other: no gum
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Not yet recruiting - verified February 2010
Conditions: Diabetes Mellitus, Type 2; Renal Insufficiency
Interventions: Drug: Canagliflozin 100 mg; Drug: Placebo; Drug: Canagliflozin 300 mg
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Not yet recruiting - verified February 2010
Condition: Diabetic Foot Ulcers
Interventions: Drug: MEBO Wound Ointment (MEBO); Drug: Sterile Saline Moistened Gauze
Sponsor: Skingenix, Inc.
Not yet recruiting - verified February 2010
Condition: Proliferative Diabetic Retinopathy Induced Rubeosis
Intervention: Drug: Ranibizumab
Sponsors: Bhagat, Neelakshi, M.D., M.P.H.; Genentech
Recruiting - verified February 2010
Condition: Colon, Irritable
Intervention:
Sponsors: The University of North Carolina, Chapel Hill; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified February 2010
Conditions: Inflammation; Colon, Irritable; Colonic Diseases, Functional; Irritable Bowel Syndrome
Intervention:
Sponsors: The University of North Carolina, Chapel Hill; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified February 2010
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Placebo; Drug: 1 mg PF-04971729; Drug: 5 mg PF-04971729; Drug: 10 mg PF-04971729; Drug: 25 mg PF-04971729; Drug: 100 mg sitagliptin
Sponsor: Pfizer
Recruiting - verified March 2010
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: NN5401; Drug: biphasic insulin aspart 30
Sponsor: Novo Nordisk
Recruiting - verified February 2010
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: NN1250; Drug: insulin glargine
Sponsor: Novo Nordisk
Recruiting - verified February 2010
Condition: Healthy Volunteers
Intervention: Drug: PF-04620110
Sponsor: Pfizer
Recruiting - verified March 2010
Conditions: Resistant Hypertension; NIDDM
Intervention:
Sponsor: Svendborg Hospital
Recruiting - verified November 2009
Conditions: Diabetic Neuropathy, Painful; Diabetic Polyneuropathy
Interventions: Drug: Oxycodone controlled release (CR); Drug: Tapentadol extended release (ER)
Sponsors: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.; Grünenthal GmbH
Recruiting - verified February 2010
Conditions: Renal Insufficiency, Chronic; Diabetes Mellitus, Type 2
Intervention: Drug: Bardoxolone methyl (amorphous dispersion)
Sponsor: Reata Pharmaceuticals, Inc.
Recruiting - verified March 2010
Conditions: Diabetes Mellitus, Type 2; Adult
Interventions: Drug: 2 mg single dose; Drug: 2 mg split into twice daily; Drug: 4 mg single dose; Drug: 4 mg split into twice daily
Sponsor: Pfizer
Not yet recruiting - verified March 2010
Condition: Type 1 Diabetes Mellitus
Interventions: Drug: SAR161271; Drug: Insulin glargine HOE901
Sponsor: Sanofi-Aventis
Recruiting - verified February 2010
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: taspoglutide; Drug: taspoglutide; Drug: insulin glargine; Drug: metformin
Sponsor: Hoffmann-La Roche
Recruiting - verified February 2010
Condition: Diabetic Neuropathy, Painful
Interventions: Drug: Pregabalin; Drug: Placebo
Sponsor: Pfizer
Not yet recruiting - verified March 2010
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: LY2605541; Drug: Insulin glargine
Sponsor: Eli Lilly and Company
Recruiting - verified February 2010
Condition: Diabetes Type 2
Interventions: Drug: BMS-770767; Drug: BMS-770767; Drug: BMS-770767; Drug: BMS-770767; Drug: Placebo; Drug: Metformin
Sponsor: Bristol-Myers Squibb
Not yet recruiting - verified January 2010
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: NN5401; Drug: insulin glargine
Sponsor: Novo Nordisk
Recruiting - verified February 2010
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: NN1250; Drug: sitagliptin
Sponsor: Novo Nordisk
Recruiting - verified March 2010
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Placebo; Drug: PF-04937319
Sponsor: Pfizer
Recruiting - verified February 2010
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: aleglitazar; Drug: pioglitazone
Sponsor: Hoffmann-La Roche
Not yet recruiting - verified February 2010
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Aleglitazar; Drug: Placebo
Sponsor: Hoffmann-La Roche
Not yet recruiting - verified February 2010
Condition: Obesity
Interventions: Behavioral: More-Intensive; Behavioral: Less-Intensive
Sponsors: University of Pittsburgh; Milton S. Hershey Medical Center; Department of Defense
Not yet recruiting - verified March 2010
Condition: Hypertriglyceridemia
Interventions: Drug: AMR101 (ethyl icosapentate); Drug: AMR101 (ethyl icosapentate); Drug: Placebo
Sponsor: Amarin Pharma Inc.
Recruiting - verified February 2010
Conditions: Healthy; Diabetes Mellitus, Type 2
Interventions: Drug: NN9924 (oral); Drug: placebo; Drug: NN9924 (oral); Drug: placebo; Drug: NN9924 (s.c.); Drug: NN9924 (i.v.)
Sponsor: Novo Nordisk
Recruiting - verified March 2010
Conditions: Diabetic Neuropathy, Painful; Diabetic Polyneuropathy
Interventions: Drug: tapentadol extended release (ER); Drug: placebo
Sponsors: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.; Grünenthal GmbH
Recruiting - verified February 2010
Condition: Diabetes
Interventions: Drug: MBX-2982; Drug: MBX-2982; Drug: MBX-2982; Drug: Sitagliptin; Drug: placebo
Sponsor: Metabolex
Recruiting - verified March 2010
Condition: Influenza
Intervention: Other: Non-intervention observational study
Sponsors: Novartis; Novartis Vaccines
Recruiting - verified February 2010
Conditions: Diabetes Mellitus, Type 2; Cardiovascular Diseases; Risk Factors
Interventions: Drug: Canagliflozin on background standard of care for diabetes; Drug: Placebo on background standard of care for diabetes
Sponsors: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.; George Institute, Sydney, Australia
Recruiting - verified February 2010
Conditions: Type 2 Diabetes Mellitus; Cardiovascular Disease; Hypertension; Inadequate Glycaemic Control
Interventions: Drug: Dapagliflozin; Drug: Placebo
Sponsors: AstraZeneca; Bristol-Myers Squibb
Recruiting - verified March 2010
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: LY2599506; Drug: Glyburide; Drug: Placebo
Sponsor: Eli Lilly and Company
Recruiting - verified February 2010
Condition: Diabetes Mellitus Type 2
Interventions: Drug: EGT0001442; Drug: Placebo capsules to match EGT0001442
Sponsor: Theracos
Recruiting - verified February 2010
Condition: Painful Diabetic Neuropathy
Interventions: Drug: GRT3983Y; Drug: Placebo
Sponsor: Grünenthal GmbH
Recruiting - verified February 2010
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: exenatide once weekly; Drug: liraglutide
Sponsors: Amylin Pharmaceuticals, Inc.; Eli Lilly and Company
Recruiting - verified December 2009
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: LY2605541; Drug: insulin glargine
Sponsor: Eli Lilly and Company
Recruiting - verified February 2010
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Placebo; Drug: pioglitazone; Drug: CCX140-B; Drug: CCX140-B
Sponsor: ChemoCentryx
Recruiting - verified February 2010
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Placebo; Drug: LY2599506
Sponsor: Eli Lilly and Company
Recruiting - verified February 2010
Condition: Diabetes Mellitus, Type II
Intervention: Other: Metabolic Testing
Sponsors: University of Washington; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified February 2010
Condition: Breast Cancer
Intervention: Drug: Duloxetine
Sponsors: University of Michigan Cancer Center; Eli Lilly and Company
Recruiting - verified February 2010
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: taspoglutide; Drug: placebo
Sponsor: Hoffmann-La Roche
Recruiting - verified March 2010
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Placebo; Drug: SRT2104
Sponsor: GlaxoSmithKline
Recruiting - verified March 2010
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: RO5095932; Drug: Placebo; Drug: RO5095932; Drug: Placebo
Sponsor: Hoffmann-La Roche
Recruiting - verified February 2010
Condition: Type 2 Diabetes
Interventions: Behavioral: Telephone support and behavior change; Other: Diabetes self-management education
Sponsor: State University of New York - Upstate Medical University
Recruiting - verified February 2010
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: RO4998452; Drug: Placebo
Sponsor: Hoffmann-La Roche
Recruiting - verified February 2010
Condition: Kidney Transplant
Interventions: Drug: Everolimus and tacrolimus; Drug: CellCept® and tacrolimus
Sponsor: Novartis
Recruiting - verified February 2010
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: BI 10773; Drug: BI 10773; Drug: BI 10773
Sponsor: Boehringer Ingelheim Pharmaceuticals
Recruiting - verified March 2010
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: linagliptin low dose; Drug: placebo; Drug: linagliptin medium dose
Sponsor: Boehringer Ingelheim Pharmaceuticals
Recruiting - verified March 2010
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: TAK-875 6.25 mg; Drug: TAK-875 25 mg; Drug: TAK-875 50 mg; Drug: TAK-875 100 mg; Drug: TAK-875 200 mg; Drug: Glimepiride 2 mg or 4mg; Drug: Placebo
Sponsor: Takeda Global Research & Development Center, Inc.
Recruiting - verified February 2010
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Saxagliptin; Drug: Metformin
Sponsors: AstraZeneca; Bristol-Myers Squibb
Recruiting - verified March 2010
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Saxagliptin; Drug: Glimepiride
Sponsors: AstraZeneca; Bristol-Myers Squibb
Recruiting - verified February 2010
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: DLBS-32; Drug: DLBS-32; Drug: DLBS-32; Drug: DLBS-32; Drug: Placebo capsule
Sponsor: Dexa Medica Group
Recruiting - verified March 2010
Condition: Type 2 Diabetes Mellitus (T2DM)
Interventions: Drug: Dapagliflozin; Drug: Metformin XR; Drug: Glucophage
Sponsors: Bristol-Myers Squibb; AstraZeneca
Recruiting - verified January 2010
Conditions: Obesity; Overweight; Diabetes
Intervention:
Sponsor: Surgical Review Corporation
Recruiting - verified November 2009
Condition: Diabetes Mellitus, Type 1
Intervention: Drug: Xoma 052
Sponsors: University of Zurich; Prof. M. Donath; Juvenile Diabetes Research Foundation; XOMA (US) LLC
Recruiting - verified March 2010
Conditions: Diabetes Mellitus, Type 2; Obesity
Interventions: Behavioral: Sport; Drug: Tocilizumab; Drug: Sitagliptin
Sponsors: University of Zurich; Donath M.Y.; European Foundation for the study of Diabetes
Recruiting - verified February 2010
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: exenatide once weekly; Drug: insulin detemir
Sponsors: Amylin Pharmaceuticals, Inc.; Eli Lilly and Company
Recruiting - verified December 2009
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Linagliptin; Drug: Linagliptin; Drug: Placebo
Sponsor: Boehringer Ingelheim Pharmaceuticals
Recruiting - verified March 2010
Condition: Type 1 Diabetes Mellitus
Interventions: Drug: INSULIN GLARGINE (HOE901); Drug: Neutral Protamine Hagedorn (NPH) insulin
Sponsor: Sanofi-Aventis
Recruiting - verified February 2010
Condition: Diabetes Mellitus, Non-Insulin-Dependent
Interventions: Drug: Janumet/MK0431A (sitagliptin phosphate (+) metformin hydrochloride); Drug: Comparator: glimepiride
Sponsor: Merck
Not yet recruiting - verified March 2010
Conditions: Pain; Diabetic Neuropathy, Painful
Interventions: Drug: Placebo; Drug: JNJ-42160443
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Recruiting - verified February 2010
Condition: Type II Diabetes
Interventions: Device: EndoBarrier; Behavioral: Diet + Lifestyle Counseling
Sponsor: GI Dynamics
Recruiting - verified February 2010
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Insulin Lispro; Drug: Huminsulin Regular; Device: Huma Pen Memoir; Device: Huma Pen Luxura
Sponsor: Eli Lilly and Company
Recruiting - verified February 2010
Condition: Type 2 Diabetes
Intervention: Other: Simulated Diabetes Training
Sponsors: HealthPartners Research Foundation; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Not yet recruiting - verified March 2010
Conditions: Type 2 Diabetes; Dyslipidemia
Interventions: Drug: BMS-816336; Drug: BMS-816336; Drug: BMS-816336; Drug: BMS-816336; Drug: BMS-816336; Drug: Placebo
Sponsor: Bristol-Myers Squibb
Recruiting - verified October 2009
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Lixisenatide (AVE0010); Drug: Sitagliptin
Sponsor: Sanofi-Aventis
Recruiting - verified March 2010
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Dapagliflozin; Drug: Placebo; Drug: Hydrochlorothiazide
Sponsors: Bristol-Myers Squibb; AstraZeneca
Recruiting - verified December 2009
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: insulin glargine + preprandial lispro insulin; Biological: albiglutide + insulin glargine
Sponsor: GlaxoSmithKline
Recruiting - verified March 2010
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: lixisenatide (AVE0010); Drug: placebo; Drug: insulin glargine (HOE901)
Sponsor: Sanofi-Aventis
Recruiting - verified March 2010
Condition: Type 2 Diabetes
Interventions: Drug: MK8245; Drug: Comparator: placebo
Sponsor: Merck
Recruiting - verified March 2010
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: MP-513 Lowest Dose and Metformin; Drug: MP-513 Low Dose and Metformin; Drug: MP-513 Medium Dose and Metformin; Drug: MP-513 High Dose and Metformin; Drug: Placebo and Metformin
Sponsor: Mitsubishi Tanabe Pharma Corporation
Recruiting - verified March 2010
Condition: Diabetes Mellitus, Type II
Interventions: Drug: Placebo; Drug: Dutogliptin
Sponsors: Forest Laboratories; Phenomix
Recruiting - verified February 2010
Condition: Diabetes Mellitus, Type 2
Intervention: Drug: Lispro Mix 50/50
Sponsor: Eli Lilly and Company
Recruiting - verified February 2010
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Acarbose (Glucobay, BAYG5421); Drug: Voglibose (Basen)
Sponsor: Bayer
Recruiting - verified February 2010
Conditions: Diabetes Mellitus, Type 2; Acute Coronary Syndrome
Interventions: Drug: Alogliptin; Drug: Placebo
Sponsor: Takeda Global Research & Development Center, Inc.
Recruiting - verified March 2010
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: glimepiride; Drug: JNJ-28431754
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Recruiting - verified February 2010
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: INSULIN GLARGINE (HOE901); Drug: Insulin aspart; Drug: Insulin Glulisine
Sponsor: Sanofi-Aventis
Recruiting - verified March 2010
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: RO5095932; Drug: RO5095932; Drug: placebo; Drug: metformin
Sponsor: Hoffmann-La Roche
Recruiting - verified February 2010
Conditions: Diabetic Foot Ulcers; Pressure Ulcers
Interventions: Device: HP828-101; Device: Hydrogel/Hydrocolloid
Sponsor: Healthpoint
Recruiting - verified March 2010
Condition: Type 2 Diabetes
Interventions: Drug: Saxagliptin; Drug: Metformin XR; Drug: Metformin XR
Sponsors: AstraZeneca; Bristol-Myers Squibb
Recruiting - verified February 2010
Condition: Neoplasms
Intervention: Drug: BAY80-6946
Sponsor: Bayer
Recruiting - verified March 2010
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Alogliptin; Drug: Alogliptin; Drug: Alogliptin; Drug: Alogliptin; Drug: Alogliptin
Sponsor: Takeda Global Research & Development Center, Inc.
Recruiting - verified February 2010
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Placebo; Drug: Linagliptin
Sponsor: Boehringer Ingelheim Pharmaceuticals
Recruiting - verified March 2010
Conditions: Obesity; Overweight; Healthy
Interventions: Drug: PF-04620110; Drug: Placebo
Sponsors: Pfizer; Bristol-Myers Squibb
Recruiting - verified March 2010
Condition: Chronic Hepatitis C
Intervention: Drug: Pegylated Interferons (Peg-IFN) and Ribavirin
Sponsors: University of Manitoba; Roche Pharma AG
Recruiting - verified February 2010
Conditions: Type 1 Diabetes; Eating Disorder
Intervention:
Sponsors: Park Nicollet Institute; International Diabetes Center at Park Nicollet; Park Nicollet Eating Disorder Institute; Park Nicollet Foundation
Recruiting - verified February 2010
Condition: Type 2 Diabetes Mellitus
Intervention: Other: There are no interventions, this is not a treatment study.
Sponsor: Washington University School of Medicine
Not yet recruiting - verified February 2010
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Insulin Glargine (HOE901) [Lantus]; Drug: Glimepiride; Drug: human insulin [NPH]
Sponsor: Sanofi-Aventis
Recruiting - verified March 2010
Conditions: Diabetes Mellitus, Type 2; Hyperglycemia
Interventions: Behavioral: Exercise intervention; Behavioral: No exercise
Sponsors: Maastricht University Medical Center; ZonMw: The Netherlands Organisation for Health Research and Development
Recruiting - verified February 2010
Condition: Diabetes Mellitus, Type II
Interventions: Drug: Dutogliptin; Drug: Placebo
Sponsors: Forest Laboratories; Phenomix
Recruiting - verified February 2010
Condition: Bariatric Surgery
Intervention: Other: Observational study - there is no intervention
Sponsors: Christiana Care Health Services; American Society for Metabolic and Bariatric Surgery
Recruiting - verified March 2010
Condition: Type 1 Diabetes Mellitus
Intervention: Drug: Otelixizumab
Sponsor: GlaxoSmithKline
Recruiting - verified March 2010
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: liraglutide; Drug: placebo; Drug: liraglutide; Drug: placebo; Drug: liraglutide; Drug: placebo
Sponsor: Novo Nordisk
Recruiting - verified February 2010
Condition: Type 2 Diabetes
Interventions: Drug: LY2189102; Drug: Placebo
Sponsor: Eli Lilly and Company
Recruiting - verified February 2010
Condition: Type 2 Diabetes Mellitus
Intervention: Drug: Detemir insulin, Aspart insulin, Metformin
Sponsor: University Hospital, Toulouse
Recruiting - verified February 2010
Conditions: Type 2 Diabetes; Major Depressive Disorder
Interventions: Behavioral: Diabetes and depression intervention; Behavioral: Diabetes intervention
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Not yet recruiting - verified March 2010
Condition: Type 2 Diabetes
Interventions: Device: placebo; Device: IVS; Device: PDAphone
Sponsors: Centre d’Etudes et de Recherche pour l’Intensification du Traitement du Diabète; Novo Nordisk
Recruiting - verified March 2010
Condition: Diabetes
Intervention: Drug: Aliskiren
Sponsor: Christiana Care Health Services
Recruiting - verified March 2010
Condition: Type 1 Diabetes
Interventions: Other: Therapeutic and preventive strategies; Other: Therapeutic and preventive strategies
Sponsors: Centre d’Etudes et de Recherche pour l’Intensification du Traitement du Diabète; University Hospital
Recruiting - verified February 2010
Condition: Gestational Diabetes Mellitus
Intervention: Other: Determining a change in heart rate variability post delivery of the baby
Sponsor: Christiana Care Health Services
Recruiting - verified March 2010
Condition: Diabetes Mellitus, Type 2
Intervention: Drug: RO4998452
Sponsor: Hoffmann-La Roche
Recruiting - verified February 2010
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Placebo; Drug: SRT2104
Sponsor: GlaxoSmithKline
Recruiting - verified March 2010
Condition: Diabetes Mellitus, Type 2
Intervention: Drug: linagliptin QD for 7 days
Sponsor: Boehringer Ingelheim Pharmaceuticals
Recruiting - verified March 2010
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Nateglinide; Drug: Acarbose
Sponsor: Novartis
Recruiting - verified March 2010
Conditions: Cardiovascular Disease; Diabetes
Intervention:
Sponsor: Johnson & Johnson Medical, China
Recruiting - verified October 2009
Conditions: Hypertriglyceridemia; Diabetic Neuropathy
Intervention: Drug: omega-3-acie ethyl esters
Sponsors: Eastern Virginia Medical School; GlaxoSmithKline
Recruiting - verified March 2010
Conditions: Frozen Shoulder; Impairment Glucose Tolerance
Intervention:
Sponsor: Hadassah Medical Organization
Recruiting - verified February 2010
Condition: Type 1 Diabetes Mellitus
Interventions: Drug: Teplizumab (MGA031); Drug: Placebo
Sponsors: MacroGenics; Eli Lilly and Company
Recruiting - verified March 2010
Condition: Type 2 Diabetes
Interventions: Drug: Saxagliptin; Drug: Metformin XR; Drug: Placebo matching Metformin 500 mg; Drug: Metformin XR; Drug: Placebo matching Saxagliptin 5 mg
Sponsors: Bristol-Myers Squibb; AstraZeneca
Recruiting - verified February 2010
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: exenatide once weekly; Drug: exenatide twice daily
Sponsors: Amylin Pharmaceuticals, Inc.; Eli Lilly and Company
Recruiting - verified February 2010
Conditions: Neuroblastoma; Sarcoma; Rhabdomyosarcoma-Embryonal; Rhabdomyosarcoma- Alveolar; Neuroectodermal Tumors, Primitive, Peripheral
Interventions: Drug: Tumor Purged/CD25 Depleted Lymphocytes; Biological: Tumor Purged/CD25 Depleted Lymphocytes with Tumor Lysate/KLH Pulsed Dendritic Cell Vaccine; Drug: IL-4; Device: Miltenyi CliniMACS-System; Drug: Tumor Lysate/KLH Pulsed Dendritic Cell Vaccine; Drug: KLH; Drug: MAB 8H9; Drug: Endotoxin
Sponsor: National Cancer Institute (NCI)
Recruiting - verified February 2010
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Linagliptin + metformin; Drug: Linagliptin+metformin; Drug: Metformin
Sponsor: Boehringer Ingelheim Pharmaceuticals
Recruiting - verified March 2010
Conditions: Diabetic Nephropathy; Chronic Kidney Disease
Interventions: Drug: Placebo for Atrasentan 0,2 mg/mL solution; Drug: 0.25 mg Atrasentan QD; Drug: 0.75 mg Atrasentan QD; Drug: 1.75 mg Atrasentan QD
Sponsor: Abbott
Recruiting - verified January 2010
Condition: Diabetic Retinopathy
Interventions: Drug: doxycycline monohydrate; Drug: Placebo
Sponsors: Penn State University; Juvenile Diabetes Research Foundation
Recruiting - verified March 2010
Condition: Diabetes Mellitus
Intervention: Drug: Acarbose, Glucobay (BAYG5421)
Sponsor: Bayer
Recruiting - verified March 2010
Condition: Diabetes Mellitus, Type 2
Intervention: Biological: CVX-096
Sponsor: Pfizer
Recruiting - verified March 2010
Condition: Type 2 Diabetes
Interventions: Drug: Saxagliptin plus metformin IR; Drug: Placebo plus metformin IR
Sponsors: Bristol-Myers Squibb; AstraZeneca
Recruiting - verified October 2009
Condition: Diabetes Mellitus, Type 2
Intervention: Drug: CNTO 3649; Placebo
Sponsor: Centocor, Inc.
Recruiting - verified February 2010
Condition: Diabetes
Interventions: Drug: Cyclo-Z; Drug: Placebo
Sponsor: Department of Veterans Affairs
Recruiting - verified February 2010
Conditions: Cardiovascular Disease; Type 2 Diabetes Mellitus
Interventions: Drug: pioglitazone; Drug: placebo; Dietary Supplement: vitamin D; Dietary Supplement: placebo; Drug: rosiglitazone
Sponsor: GlaxoSmithKline
Recruiting - verified February 2010
Condition: Euvolemic Hyponatremia
Interventions: Drug: Lixivaptan; Drug: Placebo
Sponsors: CardioKine Inc.; Cardiokine Biopharma, LLC; Biogen Idec
Recruiting - verified March 2010
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: MK3577; Drug: Comparator: Placebo; Drug: MK3577; Drug: MK3577; Drug: Comparator: metformin
Sponsor: Merck
Recruiting - verified March 2010
Conditions: Diabetes Mellitus; Overweight
Intervention: Behavioral: Lifestyle Intervention
Sponsors: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Cascadia Behavioral Healthcare; Oregon Health and Science University; University of Medicine and Dentistry New Jersey
Not yet recruiting - verified March 2010
Condition: Gestational Diabetes
Intervention: Behavioral: Stepping Up to Health
Sponsors: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University of Michigan
Recruiting - verified March 2010
Condition: Spinal Cord Injury
Intervention:
Sponsor: Department of Veterans Affairs
Recruiting - verified March 2010
Condition: Diabetes Mellitus Type II Non Insulin Dependent
Interventions: Dietary Supplement: Vitamin E; Dietary Supplement: Vitamin C; Dietary Supplement: Lipid Oxidation
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified January 2010
Condition: Diabetic Neuropathies
Interventions: Drug: Carisbamate 800 mg/d; Drug: Pregabalin 300 mg/d; Drug: Placebo; Drug: Carisbamate 1,200 mg/d
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Recruiting - verified February 2010
Conditions: Cardiovascular Disorder; Diabetes Mellitus
Interventions: Drug: ezetimibe (+) simvastatin; Drug: Comparator: simvastatin 40 mg or atorvastatin 20 mg; Drug: Comparator: rosuvastatin; Drug: Comparator: atorvastatin 10 mg or simvastatin 20 mg
Sponsor: Merck
Recruiting - verified March 2010
Condition: Diabetes, Type 2
Interventions: Drug: saxagliptin; Drug: saxagliptin; Drug: saxagliptin; Drug: placebo
Sponsor: Otsuka Pharmaceutical Co., Ltd.
Recruiting - verified March 2010
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Alogliptin and metformin; Drug: Alogliptin and metformin; Drug: Glipizide and metformin
Sponsor: Takeda Global Research & Development Center, Inc.
Recruiting - verified March 2010
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Insulin Glargine; Drug: Sitagliptin
Sponsor: Sanofi-Aventis
Recruiting - verified March 2010
Conditions: Obesity; Diabetes
Intervention: Behavioral: lifestyle intervention
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified January 2010
Conditions: Gastroparesis; Diabetic Gastroparesis; Diabetes; Diabetes Mellitus; Delayed Gastric Emptying
Interventions: Drug: metoclopramide; Drug: Placebo
Sponsor: Evoke Pharma
Recruiting - verified March 2010
Condition: Premature Birth
Interventions: Behavioral: Provision of Interpregnancy Care; Behavioral: Interpregnancy Care
Sponsors: University of Mississippi Medical Center; Mississippi State Department of Health; Federally Qualified Community Health Centers
Recruiting - verified February 2010
Condition: Essential Hypertension
Interventions: Drug: TAK-491 and chlorthalidone; Drug: TAK-491 and chlorthalidone; Drug: Olmesartan medoxomil-hydrochlorothiazide
Sponsor: Takeda Global Research & Development Center, Inc.
Recruiting - verified March 2010
Conditions: Nephropathy; Retinopathy; Hypertension; Obesity; Diabetes
Intervention:
Sponsor: National Human Genome Research Institute (NHGRI)
Recruiting - verified January 2009
Conditions: Diabetic Neuropathies; Depressive Disorder, Major
Interventions: Drug: Duloxetine 30 mg QD; Drug: Duloxetine 30 mg QD; Drug: Duloxetine 30 mg QD; Drug: Duloxetine 30 mg QD; Drug: Duloxetine 60 mg QD; Drug: Duloxetine 60 mg QD; Drug: Duloxetine 60 mg QD; Drug: Duloxetine 60 mg QD
Sponsor: Boehringer Ingelheim Pharmaceuticals
Recruiting - verified March 2010
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Dapagliflozin; Drug: Placebo
Sponsors: Bristol-Myers Squibb; AstraZeneca
Recruiting - verified October 2009
Conditions: Diabetes Mellitus, Type 2; Renal Impairment
Intervention: Drug: NN9535
Sponsor: Novo Nordisk
Recruiting - verified March 2010
Conditions: Coronary Heart Disease; Acute Coronary Syndrome; Impaired Glucose Tolerance; Type 2 Diabetes Mellitus (T2DM)
Interventions: Drug: Acarbose; Drug: Matching Placebo
Sponsors: University of Oxford; Bayer
Recruiting - verified March 2010
Condition: Diabetic Peripheral Neuropathic Pain
Interventions: Behavioral: CBT plus standard pharmaceutical care (CBT/SC); Behavioral: Diabetic Education plus standard pharmaceutical care (ED/SC)
Sponsor: Department of Veterans Affairs
Not yet recruiting - verified February 2010
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: taspoglutide; Drug: placebo
Sponsor: Hoffmann-La Roche
Recruiting - verified February 2010
Condition: Peripheral Vascular Disease
Interventions: Procedure: Conventional angioplasty balloon; Procedure: cryoplasty balloon
Sponsors: Boston Scientific Corporation; Texas Health Resources
Recruiting - verified January 2010
Conditions: Chronic Kidney Disease; Iron-Deficiency Anemia
Interventions: Drug: IV Iron; Drug: Ferrous Sulfate
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified March 2010
Conditions: Eating Disorder; Type 1 Diabetes
Intervention: Behavioral: ED/DM Support Group
Sponsors: Park Nicollet Institute; International Diabetes Center at Park Nicollet; Park Nicollet Eating Disorder Institute; Park Nicollet Foundation
Recruiting - verified February 2010
Conditions: Thyroid Disease; Healthy
Intervention:
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified October 2009
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: RO4998452; Drug: RO4998452; Drug: RO4998452; Drug: RO4998452; Drug: RO4998452; Drug: Placebo
Sponsor: Hoffmann-La Roche
Recruiting - verified February 2010
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Salsalate; Drug: Salsalate Placebo
Sponsors: Joslin Diabetes Center; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified February 2010
Conditions: Corneal Epithelial Defect; Diabetic Retinopathy; Penetrating Keratoplasty
Intervention: Other: autologous serum
Sponsor: National Taiwan University Hospital
Recruiting - verified February 2010
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Sitagliptin phosphate; Drug: Comparator: Placebo
Sponsors: Merck; Duke Clinical Research Institute, Oxford Diabetes Trials Unit
Recruiting - verified March 2010
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Welchol; Drug: placebo tablets
Sponsor: Daiichi Sankyo Inc.
Recruiting - verified March 2010
Condition: Healthy Subjects
Interventions: Drug: 20% lipid infusion; Drug: glycerol
Sponsor: University of Minnesota - Clinical and Translational Science Institute
Recruiting - verified February 2010
Condition: Type 2 Diabetes Mellitus
Intervention: Drug: Metformin XR
Sponsor: Bristol-Myers Squibb
Recruiting - verified January 2010
Condition: Diabetic Neuropathy, Painful
Interventions: Drug: Placebo; Drug: pregabalin; Drug: LY545694; Drug: LY545694; Drug: LY545694
Sponsor: Eli Lilly and Company
Recruiting - verified February 2010
Condition: Diabetes
Interventions: Other: Calorie Restriction; Other: Exercise; Other: Calorie Restriction plus Exercise
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified February 2010
Conditions: Pre-diabetes; Type 2 Diabetes
Interventions: Drug: Exenatide; Drug: Sitagliptin; Drug: Glimepiride
Sponsors: University of Pennsylvania; Pennsylvania Department of Health
Recruiting - verified March 2010
Condition: Diabetic Macular Edema
Interventions: Drug: Aliskiren; Drug: Placebo
Sponsor: Novartis Pharmaceuticals
Recruiting - verified February 2010
Conditions: Diabetes Insipidus; Diagnosis
Intervention:
Sponsor: University Hospital, Basel, Switzerland
Recruiting - verified February 2010
Condition: Type 2 Diabetes
Interventions: Drug: Saxagliptin; Drug: Placebo
Sponsors: Bristol-Myers Squibb; AstraZeneca
Recruiting - verified October 2009
Condition: Diabetic Foot Ulcer
Intervention: Drug: Fragmin
Sponsor: Pfizer
Recruiting - verified March 2010
Conditions: Weight Loss; Diabetes Mellitus, Type 2; Psychotic Disorders
Intervention: Behavioral: Premier Lifestyle Intervention with DASH Diet
Sponsor: Kaiser Permanente
Recruiting - verified March 2010
Condition: Type 1 Diabetes Mellitus
Interventions: Drug: rhGAD65; Drug: rhGAD65; Drug: Placebo
Sponsor: Diamyd Therapeutics AB
Recruiting - verified March 2010
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Insulin Glargine; Drug: Sitagliptin
Sponsor: Sanofi-Aventis
Recruiting - verified March 2010
Condition: Obesity
Interventions: Behavioral: Individual telephone intervention; Behavioral: Group telephone intervention
Sponsors: State University of New York - Upstate Medical University; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified February 2010
Conditions: Inflammation; Insulin Sensitivity
Interventions: Other: Weight Loss; Other: Aerobic Exercise Training
Sponsor: Department of Veterans Affairs
Recruiting - verified February 2010
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: taspoglutide; Drug: taspoglutide; Drug: placebo
Sponsor: Hoffmann-La Roche
Recruiting - verified February 2010
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: taspoglutide; Drug: taspoglutide; Drug: placebo; Drug: pioglitazone; Drug: metformin
Sponsor: Hoffmann-La Roche
Recruiting - verified February 2010
Condition: Sleep Apnea
Interventions: Procedure: Modified tonsillectomy; Other: Lifestyle counselling by physician
Sponsor: Kuopio University Hospital
Recruiting - verified March 2010
Condition: Glucose Intolerance
Interventions: Drug: sitagliptin; Drug: placebo
Sponsors: University of Oslo School of Pharmacy; Rikshospitalet HF
Recruiting - verified March 2010
Condition: Type II Diabetes Mellitus
Intervention: Other: Rosiglitazone with diet and exercise
Sponsors: American Scitech International; Proactive Clinical Research; GlaxoSmithKline
Not yet recruiting - verified March 2010
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: LY2189265; Drug: Sitagliptin 100mg, 24 months; Drug: Placebo solution; Drug: Placebo tablet, 6 months; Drug: Placebo tablet, 24 months; Drug: Sitagliptin 100 mg, 18 months
Sponsors: Eli Lilly and Company; United BioSource Corporation; Tessella Inc.; Berry Consultants
Recruiting - verified March 2010
Condition: Diabetes Mellitus
Interventions: Drug: Exubera; Other: Randomized diabetes therapy
Sponsor: Pfizer
Recruiting - verified March 2010
Condition: Type 2 Diabetes
Intervention: Drug: sitagliptin phosphate
Sponsor: Merck
Recruiting - verified March 2010
Condition: Diabetes Mellitus
Interventions: Drug: Comparison of the effect of aldosterone versus vehicle infusion; Drug: Comparison of the effect of aldosterone versus vehicle infusion
Sponsors: Vanderbilt University; National Heart, Lung, and Blood Institute (NHLBI); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified February 2010
Condition: Subjects With Metabolic Syndrome Are at High Risk for Diabetes
Intervention: Behavioral: strength training
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Not yet recruiting - verified March 2010
Condition: Type 2 Diabetes
Intervention:
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified March 2010
Condition: Liver Transplantation
Interventions: Drug: mycophenolate mofetil [CellCept]; Drug: CNI; Drug: CNI
Sponsor: Hoffmann-La Roche
Recruiting - verified February 2010
Condition: Hepatitis C, Chronic
Interventions: Procedure: Liver Biopsy; Drug: Peginterferon & Ribavirin for Hepatitis C; Drug: Pre-treatment Ribavirin
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified May 2009
Condition: Diabetic Retinopathy
Interventions: Drug: Sirolimus; Drug: Rapamycin
Sponsor: National Eye Institute (NEI)
Recruiting - verified March 2009
Conditions: Thalassemia; Iron Overload; Hemochromatosis
Interventions: Drug: Nifedipine; Procedure: Phlebotomy; Procedure: Urinalysis; Procedure: Echocardiogram; Procedure: Electrocardiogram
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified October 2009
Condition: Type 2 Diabetes Mellitus (T2DM)
Interventions: Drug: Comparator: sitagliptin phosphate; Drug: Comparator: placebo (unspecified)
Sponsor: Merck
Recruiting - verified March 2010
Condition: Painful Diabetic Neuropathy
Intervention: Procedure: Nerve Decompression
Sponsor: University of Texas Southwestern Medical Center
Recruiting - verified February 2010
Conditions: Diabetic Retinopathy; Diabetes Complications
Interventions: Procedure: Laser Treatment; Drug: PF-04523655 high; Drug: PF-04523655 middle; Drug: PF-04523655 low
Sponsor: Pfizer
Recruiting - verified March 2010
Condition: Obesity
Interventions: Drug: Sincalide; Drug: Ursodiol Acid; Procedure: High Fat/Low Fat Diet
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified February 2010
Condition: Obesity and Type 2 Diabetes
Interventions: Behavioral: Circuit Training; Behavioral: Circuit training + motivational interviewing; Behavioral: Control
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified March 2010
Condition: Metabolic Complications
Interventions: Drug: Metformin; Drug: Placebo
Sponsors: Rush University Medical Center; Eli Lilly and Company
Recruiting - verified February 2010
Condition: Diabetic Macular Edema
Interventions: Drug: Choline Fenofibrate; Drug: Placebo
Sponsor: Solvay Pharmaceuticals
Recruiting - verified March 2010
Conditions: Prostatitis; Cystitis, Interstitial; Urinary Bladder, Overactive; Chronic Pelvic Pain Syndrome; Painful Bladder Syndrome
Intervention:
Sponsors: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Children's Hospital Boston
Recruiting - verified March 2010
Conditions: Atherosclerosis; Diabetes Mellitus; Obesity; Dyslipidemia; Hypertension
Interventions: Behavioral: Exercise; Behavioral: Weight Loss
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified January 2010
Conditions: Proliferative Diabetic Retinopathy; Macular Edema
Interventions: Drug: ranibizumab; Drug: Ranibizumab
Sponsors: Jumper, J. Michael, M.D.; Genentech
Recruiting - verified February 2010
Conditions: Hyperglycemia; Obesity; Diabetes Mellitus
Interventions: Behavioral: Registered Dietitian Counseling Alone; Behavioral: Registered Dietitian Counseling Plus YMCA Group Lifestyle Intervention
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified March 2010
Condition: Diabetic Foot Ulcer
Interventions: Drug: Fragmin/ Dalteparin Sodium; Drug: Placebo for Fragmin/ Dalteparin Sodium
Sponsor: Pfizer
Recruiting - verified March 2010
Conditions: Chronic Hepatitis C; Atherosclerosis
Intervention:
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified September 2009
Condition: Ulcerative Colitis
Intervention: Drug: mesalamine
Sponsors: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Shire Pharmaceutical Development
Recruiting - verified February 2010
Condition: Fatty Liver Disease
Intervention: Drug: Exenatide
Sponsors: Indiana University; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified February 2010
Conditions: Coronary Artery Disease; Overweight
Interventions: Drug: Salsalate; Drug: Placebo
Sponsors: Joslin Diabetes Center; Beth Israel Deaconess Medical Center; Tufts Medical Center
Recruiting - verified February 2010
Conditions: End Stage Renal Disease; Depression
Intervention: Behavioral: Cognitive behavioral therapy
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified March 2010
Conditions: Immunosuppression; Kidney Transplantation; Graft Rejection
Intervention: Procedure: Infusion of Donor Hematopoietic Stem Cells and Campath-1H
Sponsors: Northwestern University; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified March 2010
Conditions: Metabolic Syndrome; Insulin Resistance
Interventions: Drug: omega-3 fatty acid; Drug: placebo
Sponsors: University of Kentucky; GlaxoSmithKline; National Institutes of Health (NIH)
Recruiting - verified March 2010
Conditions: Hemodialysis; Hypertension; Left Ventricular Hypertrophy
Interventions: Drug: Lisinopril; Drug: Atenolol
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified March 2010
Condition: Diabetes Mellitus Type 2
Intervention:
Sponsors: Park Nicollet Institute; Eli Lilly and Company
Recruiting - verified February 2010
Condition: Autosomal Recessive Polycystic Kidney Disease
Intervention:
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified March 2010
Condition: End-Stage Renal Disease
Intervention: Other: Blood draw
Sponsors: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University of Louisville
Recruiting - verified March 2010
Conditions: Diabetes Mellitus; Depression
Interventions: Behavioral: Enhanced treatment as usual plus adherence training; Behavioral: Enhanced treatment as usual plus CBT-AD
Sponsor: National Institute of Mental Health (NIMH)
Recruiting - verified April 2009
Condition: Hemodialysis
Intervention:
Sponsors: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Vanderbilt University; University of Utah
Recruiting - verified March 2010
Conditions: Adipocyte Differentiation; Insulin Resistance
Intervention: Other: Administration of 70% deuterated water
Sponsors: University of Vermont; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified March 2010
Conditions: Kidney Disease; Nephropathy; Type 2 Diabetes
Interventions: Drug: losartan; Drug: lisinopril; Drug: losartan
Sponsor: Department of Veterans Affairs
Recruiting - verified March 2010
Conditions: Overweight; Obesity
Interventions: Behavioral: Standard Behavioral Weight Loss Treatment with Affective and Cognitive Skills Training; Behavioral: Standard Behavioral Weight Loss Treatment
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Not yet recruiting - verified February 2010
Conditions: Aging; Exercise; Glucose Intolerance
Intervention: Behavioral: Exercise
Sponsors: Department of Veterans Affairs; American Diabetes Association
Recruiting - verified February 2010
Condition: Focal Segmental Glomerulosclerosis (FSGS)
Intervention: Drug: rituximab
Sponsors: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Genentech
Recruiting - verified March 2010
Conditions: Islet Cell Transplantation; Type 1 Diabetes
Intervention: Procedure: Islet cell transplantation
Sponsors: Baylor Research Institute; Baylor University
Recruiting - verified March 2010
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: IL-2; Drug: sirolimus
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); Immune Tolerance Network
Recruiting - verified February 2010
Condition: Obesity
Interventions: Other: Glucose tolerance test; Other: glucose tolerance test solution; Other: Diet Coke; Other: Coke Zero
Sponsor: Christiana Care Health Services
Recruiting - verified March 2010
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Antithymocyte globulin; Drug: Placebo
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); Immune Tolerance Network
Recruiting - verified January 2010
Condition: Endometrial Cancer
Intervention: Behavioral: Questionnaire
Sponsor: M.D. Anderson Cancer Center
Recruiting - verified March 2010
Condition: Type 2 Diabetes
Intervention: Behavioral: Practice Facilitation
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified March 2010
Condition: Health
Interventions: Behavioral: Focus Groups; Behavioral: Questionnaire; Behavioral: Interview
Sponsor: M.D. Anderson Cancer Center
Recruiting - verified March 2010
Condition: Childhood Obesity
Interventions: Other: Diet; Other: Diet
Sponsors: Children's Hospital Boston; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified March 2010
Conditions: Metabolic Syndrome X; Prediabetic State
Interventions: Drug: Fenofibrate; Drug: Pioglitazone and Fenofibrate; Drug: Fenofibrate; Drug: Pioglitazone and Fenofibrate
Sponsor: Department of Veterans Affairs
Recruiting - verified March 2010
Condition: Obesity
Intervention:
Sponsors: Children's Hospital Medical Center, Cincinnati; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University of Pittsburgh; University of Alabama at Birmingham; Nationwide Children's Hospital; Texas Children's Hospital; University of Washington; University of North Dakota; East Carolina University; Oregon Health and Science University
Recruiting - verified February 2010
Condition: Type 1 Diabetes Mellitus
Intervention: Drug: Otelixizumab
Sponsors: Tolerx Inc.; Juvenile Diabetes Research Foundation
Recruiting - verified June 2009
Conditions: Morbid Obesity; Diabetes Mellitus Type 2; Insulin Resistance; Obstructive Sleep Apnea; Mood Disorders
Intervention:
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified July 2009
Conditions: Type 2 Diabetes; Hyperlipidemia; Hypertension; Depression
Interventions: Behavioral: Standard CQI intervention; Behavioral: Chronic Care Improvement (CCI) Intervention; Behavioral: Self-directed practice comparison
Sponsors: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Institute of Mental Health (NIMH)
Recruiting - verified March 2010
Condition: Arthritis, Rheumatoid
Intervention: Other: CP-690,550
Sponsor: Pfizer
Recruiting - verified March 2010
Conditions: Binge Eating Disorder; Obesity
Interventions: Drug: bupropion; Other: Placebo
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified February 2010
Conditions: Atrial Fibrillation; Atrial Flutter
Interventions: Drug: warfarin; Drug: apixaban
Sponsor: Bristol-Myers Squibb
Recruiting - verified October 2009
Conditions: Vesico-Ureteral Reflux; Urinary Tract Infections
Interventions: Drug: Trimethoprim-Sulfamethoxazole; Drug: Placebo
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified March 2010
Conditions: Cystic Fibrosis; Pancreatic Insufficiency
Interventions: Dietary Supplement: Lym-X-Sorb powder; Dietary Supplement: Placebo powder
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified March 2010
Condition: Nephrolithiasis
Intervention: Drug: tamsulosin
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified March 2010
Condition: Hyperglycemias
Intervention: Drug: Novorapid ®, Novo Nordisk, Denmark
Sponsor: University Hospital, Basel, Switzerland
Recruiting - verified March 2010
Conditions: Obesity; Adipose Cell Turn Over
Intervention:
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified February 2010
Conditions: HIV Infections; AIDS; Dyslipidemia; Hypertriglyceridemia
Intervention: Drug: Omega-3 fatty acid administration
Sponsors: Brown, Todd, M.D., Ph.D.; National Center for Complementary and Alternative Medicine (NCCAM); GlaxoSmithKline, Inc.; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2010
Conditions: Overweight; Obesity
Intervention: Behavioral: WOW, Working On Wellness weight management
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified February 2010
Condition: Narcolepsy
Intervention:
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified November 2009
Conditions: Constipation; Diabetes Mellitus
Interventions: Drug: Pyridostigmine; Drug: placebo
Sponsors: Mayo Clinic; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified March 2010
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Allogenic islet cells (human, U. Chicago); Procedure: Intraportal infusion of islet cells
Sponsor: University of Chicago
Recruiting - verified February 2010
Conditions: Metabolic Syndrome X; Insulin Resistance; Obesity; Cardiovascular Diseases
Intervention: Drug: Ortho Tri Cyclen
Sponsor: Virginia Commonwealth University
Recruiting - verified February 2010
Conditions: Hepatitis C; Hepatitis C, Chronic
Interventions: Procedure: Continuous maintenance immunosuppressive therapy; Procedure: Immunosuppression withdrawal; Procedure: Liver transplant
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); Immune Tolerance Network
Recruiting - verified March 2010
Conditions: Hemoglobinopathies; Hemolysis; Iron Deficiency and Overload; Anemias
Intervention:
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified February 2010
Condition: Diabetes Mellitus
Intervention:
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified January 2010
Conditions: Diabetes Mellitus; Obesity
Intervention: Procedure: Oral glucose tolerance test
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified September 2009
Conditions: Healthy; Sickle Cell Anemia
Intervention:
Sponsors: National Heart, Lung, and Blood Institute (NHLBI); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified October 2009
Condition: Diabetic Retinopathy
Intervention:
Sponsor: National Eye Institute (NEI)
Recruiting - verified September 2009
Conditions: Endocrine Disease; Glucose Intolerance; Hyperinsulinemia; Impaired Glucose Tolerance; Non Insulin Dependent Diabetes Mellitus; Obesity; Type II Diabetes Mellitus
Intervention:
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified February 2010
Conditions: Cardiovascular Disease; Hypertension; Non Insulin Dependent Diabetes Mellitus; Obesity
Intervention:
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified February 2010
Conditions: Coronary Disease; Obesity
Intervention:
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified January 2010
Conditions: Neoplasm Metastasis; Thyroid Neoplasm; Thyroid Nodule
Intervention:
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified October 2009
All Categories ... by Medical Condition » ... Diabetes 
Login/sign up for more tools for finding clinical trials. Login/Sign up Here
